pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Impel NeuroPharma is a Seattle based clinical stage biotechnology company developing first-in-class intranasal drug treatments for central nervous system (CNS) disorders.

LOCATION

  • Seattle, WA, USA

    • THERAPEUTIC AREAS

  • Neurological Disorders

    • WEBSITE

    https://impelnp.com/

    CAREER WEBSITE

    https://impelnp.com/join-impel/

    SOCIAL MEDIA

    INVESTORS

    3m-new-ventures 5am-ventures kkr norwest-venture-partners venbio vivo-capital

    PRESS RELEASES


    Mar 1, 2021

    Impel NeuroPharma Announces Key Management Team Appointments As Company Advances Toward Commercialization In 2021


    Jan 20, 2021

    Impel NeuroPharma Announces U.S. Food and Drug Administration Acceptance Of New Drug Application For INP104 For The Acute Treatment Of Migraine


    Nov 9, 2020

    Impel Neuropharma Announces FDA Submission Of New Drug Application For INP104 For The Acute Treatment Of Migraine


    Oct 8, 2020

    Impel NeuroPharma Presents Data From Pivotal Phase 3 Registration Study Of INP104 For The Treatment Of Acute Migraine At 2020 Migraine Trust Virtual Symposium


    Jun 30, 2020

    Impel NeuroPharma Announces Publication of Positive Results of SNAP 101 Study for INP105 for the Treatment of Acute Agitation in The Journal of Clinical Psychiatry


    For More Press Releases
    Google Analytics Alternative